Keith Fowler

Keith Fowler is an experienced professional in drug safety and pharmacovigilance, currently serving as Director and Safety Scientist Lead at Genmab since September 2025. Prior experience includes a role as Senior Director at Bristol Myers Squibb from March 2019 to April 2025, where responsibilities encompassed leading a team of Pharmacovigilance Scientists in the immunology-neuroscience therapeutic area and managing asset-level support for benefit/risk profile evaluation. Previously, at Celgene as Associate Director of Global Drug Safety & Risk Management, support for safety analysis during clinical trials was provided. Additional roles include Clinical and Regulatory Analyst at Merck and Associate Director of Regulatory Analysis & Documentation at Pfizer Global Research and Development. Keith Fowler holds a Bachelor of Science in Pharmacy from Rutgers University and a Doctor of Veterinary Medicine from Tuskegee University.